Description
This formulation combines CJC-1295 (Without DAC) 5mg and Ipamorelin 5mg, providing 10mg total compound content in a pre-configured research format.
This formulation is provided to support controlled laboratory handling and reproducibility across analytical and non-clinical research workflows.